-
Anasetti C et al.
Are matched unrelated donor transplants justified for AML in CR1?
Best Pract Res Clin Haematol 2006;19:321-328.
-
Aversa F et al.
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
J Clin Oncol 2005;23:3447-3454.
-
Ball ED et al.
Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
Bone Marrow Transplant 2000;25:823-829.
-
Bensinger WI et al.
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
N Engl J Med 2001;344:175-181.
-
Buchner T et al.
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
J Clin Oncol 2006;24:2480-2489.
-
Burnett AK et al.
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
Lancet 1998;351:700-708.
-
Cassileth PA et al.
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
N Engl J Med 1998;339:1649-1656.
-
Chalandon Y et al.
Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
Biol Blood Marrow Transplant 2002;8:435-443.
-
Collisson EA et al.
Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of adult acute myelogenous leukemia in first complete remission.
Leukemia 2003;17:2183-2188.
-
Craddock C et al.
Biology and management of relapsed acute myeloid leukaemia.
Br J Haematol 2005;129:18-34.
-
de Botton S et al.
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
J Clin Oncol 2005;23:120-126.
-
de Lima M et al.
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104:865-872.
-
Drobyski WR.
The role of allogeneic transplantation in high-risk acute myelogenous leukemia.
Leukemia 2004;18:1565-1568.
-
Eyrich M et al.
A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors.
Br J Haematol 2001;114:422-432.
-
Farag SS et al.
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
J Clin Oncol 2005;23:482-493.
-
Giralt S et al.
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89:4531-4536.
-
Gorin NC.
Marrow purging: present status and future perspectives - efficacy in AML.
Prog Clin Biol Res 1992;377:251-262.
-
Gorin NC et al.
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
Leukemia 1991;5:896-904.
-
Hegenbart U et al.
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
J Clin Oncol 2006;24:444-453.
-
Heldal D et al.
Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints.
Bone Marrow Transplant 2002;29:479-486.
-
Jourdan E et al.
One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.
Br J Haematol 2005;129:403-410.
-
Kolb HJ et al.
Tolerance and chimerism.
Transplantation 2003;75:26-31.
-
Kolb HJ et al.
Graft-versus-leukemia reactions in allogeneic chimeras.
Blood 2004;103:767-776.
-
Kroger N et al.
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Bone Marrow Transplant 2000;26:711-716.
-
Lang P et al.
A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Klin Pädiatr 2005;217:334-338.
-
Lashkari A et al.
Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia.
Biol Blood Marrow Transplant 2006;12:466-471.
-
Li L et al.
Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens.
Cancer Immunol Immunother 2005;54:685-693.
-
Miller JS et al.
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Blood 2005;105:3051-3057.
-
Park KD et al.
In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive Cord Blood lymphocytes.
Blood 2006;108(5):1770-1773.
-
Platzbecker U et al.
Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia.
Leukemia 2006;20:707-714.
-
Rocha V et al.
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
N Engl J Med 2004;351:2276-2285.
-
Scheffold C et al.
Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis.
Leukemia 2004;18:2048-2050.
-
Schmid C et al.
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.
Leukemia 2004;18:1430-1433.
-
Slavin S et al.
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Blood 1998;91:756-763.
-
Socie G et al.
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
Blood 2001;98:3569-3574.
-
Stelljes M et al.
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Blood 2005;106:3314-3321.
-
Storb R et al.
Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Blood 1997;89:3048-3054.
-
Suciu S et al.
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.
Blood 2003;102:1232-1240.
-
Thiede C et al.
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers.
Leukemia 2001;15:293-302.
-
Thiede C et al.
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.
Blood 2002;99:4326-4335.
-
Wong R et al.
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
Biol Blood Marrow Transplant 2005;11:108-114.
-
Yanada M et al.
Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.
Cancer 2005;103:1652-1658.
Bildatlas Hämatologie
Druckversion
ISSN: 2193-6021
Zum Seitenanfang